Cryo-Cell Share Price

Cryo-Cell Share Price

AMEX: CCEL | Healthcare
$0.00
-$4.66 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cryo-Cell Stock Performance

Open
N/A
Prev. Close
$4.66
Circuit Range
N/A
Day Range
N/A
Year Range
$2.94 - $5.35
Volume
N/A
Average Traded
N/A

Cryo-Cell Share Price Chart

Line chart of the Cryo-Cell price trend over the selected period. The price fell overall, ranging from 4.34 to 4.75, ending at 4.66.
$0.00$0.00
L
Show Current Price
H

Cryo-Cell Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.24
Revenue (TTM)
$31.57B
Return On Equity (TTM)
11.87%
Profit Margin
-7.70%
Debt to Equity
-0.56
Quarterly Earnings Growth YoY
133.25%

Cryo-Cell Quarterly Profit & Loss

All figures in USD

ParticularsNov 2025Feb 2026May 2026Aug 2026
Revenue$7.84$7.68$7.78$7.82
Net Profit-$3.82$0.05$0.55$1.27
Net Profit Margin-48.72%0.65%7.07%16.24%
Income ChangeN/A101.31%1000.00%130.91%

Cryo-Cell Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$30.34$31.34$31.99$31.57
Net Profit$2.77-$9.52$0.40-$2.43
Net Profit Margin9.13%-30.38%1.25%-7.70%
Income ChangeN/A-443.68%104.20%-707.50%

Cryo-Cell Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets49.9752.1251.7755.28
Current Assets11.7612.559.459.61
Total Assets61.7364.6861.2264.89
Non Current Liabilities60.5456.2951.3946.93
Current Liabilities19.7921.620.8619.48
Total Liabilities80.3377.8972.2566.41
Shareholders' Equity-18.61-13.22-11.03-1.52

Cryo-Cell Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating5.486.018.928.14
Investing-0.98-4.88-8.14-15.28
Financing-4.75-0.98-2.070.58

Corporate Actions

Dividend
Ex-date: 21 May 2025

Dividend
Ex-date: 14 Feb 2025

Dividend
Ex-date: 15 Nov 2024

About Cryo-Cell

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Cryo-Cell Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.06
$4.66
-9.95%
Oct 2026
$4.11
$5.17
+26.22%
Sep 2026
$4.46
$4.10
+0.00%
Aug 2026
$3.59
$4.10
+26.74%
Jul 2026
$3.19
$3.23
-1.07%
Jun 2026
$3.40
$3.27
-4.11%
May 2026
$3.48
$3.41
-3.67%
Apr 2026
$3.59
$3.54
+5.36%
Mar 2026
$3.21
$3.36
-1.18%
Feb 2026
$3.36
$3.40
-0.29%
Jan 2026
$3.49
$3.41
-1.16%
Dec 2025
$4.07
$3.45
-15.44%

Cryo-Cell Share Price FAQs